Monday, April 16, 2018

IDIOPATHIC THROMBOCYTOPENIA PURPURA (ITP) in children : summarized


IDIOPATHIC THROMBOCYTOPENIA PURPURA (ITP)

Dr Zubair Bhutta

Ø  Most common cause of acute onset of thrombocytopenia in otherwise well child
Epidemiology:
Ø  more often in late winter and spring (peak season of viral resp. illness)
Ø  Average age is 1- 4 years
Ø  Mostly after 1-4 weeks of viral infection – auto antibodies against platelets surface
Ø  Most common viruses, Epstein-Barr viruses(short duration) and HIV (Chronic)
Ø  Also association with H.pylori infection in children
Sign and Symptoms:  (Classical Presentation of ITP)
Ø  1-4 yr healthy child has sudden onset of generalized petechiae and purpura
Ø  Bleeding from gums,epistaxis and mucosal membranes.
Ø  Platelet count (<10X109/L)
Ø  Hx of preceding viral infection 1 – 4 weeks back
Ø  No physical findings on examination other than patechiae and purpura.
Investigations:
Ø  CBC – Dec.Platelets but normal Hb and WBC
Ø  Periphral Blood Smear – normal or large platelets (megakaryocytes)
Ø  Bone marrow aspiration / biopsy –immature megakaryocytes
(Indication for BMA : 1)abnormal WBC 2)Hx and Examination suggestive of malignancy 3)HIV studies in high sexually active teens 4)Unexplained anemia 5)Plt. Antibodies testing 6)Direct Coomb’s test – if unexplained anemia with thrombocytopenia

Classification:   severity of bleeding on the basis of sign and symptoms but NOT platelet count

Minimal
Mild
Moderate
Severe
Bruising and petechiae
No
Minor
More Sever – menorrhagia occasionally
Bleeding episodes, menorrhagia and malena
Epistaxis
No
Occasional/minor
More troublesome
Severe
Quality of life
No
Little Interferance
Affected life
Hospitalization


OUTCOMES:
Ø  70 – 80 Percent spontaneously resolved within 6 months
Ø  Fewer than 1 percent develop intracranial hemorrhage
Ø  20 Percent Acute ITP become Chronic ITP

D/Ds: 1)Medication exposure 2)Early aplastic exposure i.e fanconi anemia 3)HUS 4)DIC 5)Heparin induced thrombocytopenia 6)SLE 7)HIV infection 8)Common variable of immunodeficiency
Management and Treatment:   No established benefit of treatment and PLT Tx is contraindicated unless life threatening bleeding occurs
1)      Education and counseling of family and patient
2)      Single dose if IVIG  Or IVIG for 2 DAYS:
Dose: 0.8 – 1.0 g/Kg     Side effects: Headache,Vomiting and IVIG induced aseptic meningitis
3)      Corticosteroids: Prednisone – Short course until Plt rise to >20X109/L
Dose:1 – 4 mg/kg/day  Short term Side Effects: Hypertension Long term side effects:Growth failure, Diabetes Mellitus,Osteoprosis
4)Intravenous Anti-D Therapy: Only  for Rh positive patients
Dose:50 – 75 ug/Kg     Side effects: Mild haemolytic anemia

5)Splenectomy: only indicated in 1 of these circumstances *older child >4 yrs with severe ITP lasted >1 yr *Symptoms not controlled with medical therapy * Life threatening Intracranial hemorrhage

6)Rituximab: Alternative to splenectomy

No comments:

Post a Comment

Questions related to Patent ductus arteriosus

What is patent ductus arteriosus why is it more common in neonates What is frequency of patent ductus arteriosus opening after fluid bolus d...